Abstract
Anenzyme-linked immunosorbent assay known as ELI-TEST was applied in 388 pregnant women in the gestational complication risk group who were 11– 4 weeks into pregnancy for the purpose of determining the serum content of Ig G class/that bind to double-stranded DNA, β2-glycoprotein I (β2 GP), total phospholipids (TFL), HCG vasculopathy markers (ANCA), collagen (Coll), PAPP-A, and insulin (Ins). After standardizing groups, 80 pregnant women with intrauterine growth restriction (IUGR) were selected for analysis. Characteristic changes in the levels of autoantibodies accompanying IUGR of varying severity were identified which not only gives a more accurate understanding of the pathogenesis of the disease but also enables one to define IUGR risk groups in the early stages of pregnancy.
Similar content being viewed by others
References
Strizhakov, A., Ignatko, I., Timokhina, E., & Belotserkovtseva, L. (2013). Intrauterine growth restriction syndrome: pathogenesis. Diagnostics Treatment Obstetric tactics. M: GEOTAR-Media, 120.
Sotnikova, N., & Kudryashova, A. (2008). Mechanisms for the regulation of humoral immune responses in the context ofintrauterine growth restriction syndrome. Obstetrics and Gynecology, 1, 23–26.
Poletaev, A. B., & Churilov, L. P. (2010). Immunoohysiology, natural autoimmunity and human health. Anosia, 6(1), 11–18.
Poletaev, A., & Aliyev, F. (2010). Autoantibodies and pregnancy immunopathology. Practical Medicine, 4(43), 20–24.
Herrmann, M., & Kalden, J. R. (Eds.). (2008). Apoptosis and autoimmunity (p. 387). Weinheim: Wiley-WCH.
Acknowledgments
This work was supported by the program of competitive growth of Kazan Federal University and the subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zamaleeva, R.S., Cherepanova, N.A., Frizina, A.V. et al. The Nature of Regulatory Autoantibody Changes Among Pregnant Women with Intrauterine Growth Restriction. BioNanoSci. 7, 373–375 (2017). https://doi.org/10.1007/s12668-016-0365-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12668-016-0365-z